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Genetic isolates are exceptional resources for the detection of susceptibility genes for complex diseases because of the potential reduction in
genetic and clinical heterogeneity. However, the outcome of these mapping efforts is dependent upon the demographic history of a given isolated
population, with the most significant factors being a constant population size, the number of generations since founding, and the pathogenic loci
and their allele frequencies among founders. Here we employed a cross-isolate genome-wide multipoint linkage study design using uniform
genetic and clinical methods in four Daghestan ethnically and demographically diverse isolates with an aggregation of schizophrenia. Our
previous population-genetics study showed that Daghestan has an extremely high genetic diversity between ethnic populations and a low genetic
diversity within them. The isolates selected for this study include some with more than 200 and some with fewer than 100 generations of
demographical history since their founding. Updated clinical data using DSM-IV criteria showed between-isolate differences in aggregation of
distinct types of schizophrenia: one of the isolates had a predominant aggregation of disorganized schizophrenia, while the other three had
predominantly paranoid schizophrenia. The summarized cross-isolate results indicated prominent within and between-isolate differences in
clinical and genetic heterogeneity: the most ancient isolates have roughly twofold fewer incidences of distinct clinical phenotypes and fewer linked
genomic regions compared to the demographically younger isolates, which exhibit higher clinical and genetic heterogeneity. Affected individuals
in the demographically ancient isolate of ethnic Dargins (No. 6022) who suffered from disorganized schizophrenia showed the highest linkage
evidence at 17p11–p12 (LOD=3.73), while isolates with a predominant aggregation of paranoid schizophrenia (Nos. 6005, 6011, and 6034)
showed the highest linkage evidence at 22q11 (LOD=3.0 and 4.4). The unified clinical, genomic, and statistical design we used enabled us to
separate the linked and unlinked pedigrees in an unbiased fashion for each genomic location. Overall maximized heterogeneity lod scores for the
combined pedigrees ranging from 3.5 to 8.7 were found at 2p24, 10q26, 11q23, 12q24, 17p11–p12, 22q11, and 22q13. The cross-isolate
homogeneity in linkage patterns may be ascribed to an identical-by-descent “metahaplotype” block with pathogenic loci derived from the
Daghestan ethnic groups’ common ancestral metapopulation, while the cross-isolate differences may reflect differences in gene drift and
recombination events in the history of local isolates. The results obtained support the notion that mapping genes of any complex disease (e.g.,
schizophrenia) in demographically older genetic isolates may be more time and cost effective in comparison with demographically younger
isolates, especially in genetically heterogeneous outbred populations, due to higher clinical and genetic homogeneity of the primary isolates. A
study at higher genotyping density across the regions of interest and fluorescence in situ hybridization analyses are currently underway.
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for a genetic contribution to its etiology [1,2]. Currently there are
multiple chromosomal regions with evidence for linkage to
schizophrenia, including 6p24–p22, 1q21–q22, 13q32–q34,
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E-mail address: bulaeva@vigg.ru (K.B. Bulayeva).
0888-7543/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2006.10.0011q42 [3–9]. Despite this, genomic loci identified as linked to
schizophrenia in one study are rarely verified in others at the level
of confidence required to designate these as “significant”
replications [10]. This may be due, in large part, to differences in
clinical diagnoses, genotyping methods, and genetic differences
between sampled populations. Working with these potentially
confounding factors underscores the importance of the experi-
mental design as further replications of linkage and association
1 FST, the proportion of genetic diversity attributable to population
subdivision.
Table 1
(A) Description of Daghestan genetic isolates with aggregation of schizophrenia
Isolate ID Ethnic group F Nt No. of available
affecteds
No. of pedigree
members
LMR Age of onset
6022 (P) Dargin 0.011 1340 27 314 0.0271 20.8±1.51
6005 (P) Lak 0.012 931 19 274 0.0241 24.1±2.15
6034 (S) Tindal 0.009 1800 32 539 0.0176 24.0±2.35
6011 (S) Dargin 0.007 2000 35 533 0.0297 23.2±1.89
Average 4 0.0098 1517.8 29 415 0.0246 23.03±1.98
(B) Characteristics of selected pedigrees’ fragments with schizophrenia genotyped for whole-genome scan
Category Number Range
Number of pedigree branches analyzed 5 (225) 18–69
Average number of cases per family 16.2 7–22
Average number of genotyped cases per family 9.6 6–14
Total number of affected individuals genotyped 45 6–14
Total number of unaffected individuals genotyped 40 5–14
Mean and SE of age at psychiatric hospital diagnosis 22.42±0.47 13–28
P, primary isolate; S, secondary isolate; F, mean coefficient of inbreeding in the isolate; Nt, the total number of isolate; LMR, lifetime morbidity risk.
168 K.B. Bulayeva et al. / Genomics 89 (2007) 167–177results are critical to distinguish false-positive findings from true
susceptibility loci and risk genes [11].
Genetic isolates are exceptional resources for the detection of
susceptibility genes for complex human diseases because of the
potential reduction in genetic and clinical heterogeneity.
However, the outcome of these mapping efforts is dependent
upon the demographic history of a given genetic isolate.
According to Neel’s [12] definitions, genetic isolates can be
classified as “primary” (i.e., those of a constant size, having an
ancient demographic history in a stable environment) or
“secondary” (i.e., those of an expanding size, with a younger
demographic history). Similar classification of genetic isolates
has been suggested according to number of generations since the
isolate’s foundation: very old isolates (>100 generations),
young isolates (<100 generations), and very young isolates
(<20 generations) [13].
Daghestan, located in the Northern Caucasus of Russia,
contains numerous genetically isolated populations comprising
26 indigenous ethnic groups, most of which live in the difficult to
access highland regions. Population sizes for the ethnic groups
vary from 350,000 to 700; some of these ethnic groups are so
small that they are limited to one village (700–1800 subjects). The
basic population unit among larger ethnic groups is one village;
all these villages among highlanders can be classified as “primary
isolates” according to Neel’s definition, i.e., a population
stemming from a limited number of founders with restricted
gene flow, constant size over generations, and an ancient
demographic history. Demographically younger secondary iso-
lates with significant gene flow and exogamy (intervillages and/
or interethnic marriages) exist among ethnic Kumiks that are
aboriginal lowlanders, as well as among those highlanders who
migrated to the foothill and lowland area [14–16].
Archeological and linguistic data support that most of these
ethnic groups have lived in the same highland region for more
than 10,000 years [17]. All these ethnic groups anthropologi-
cally and genetically are part of a broad European population
[14,15]. Genetic distances between Daghestan and European
ethnic groups are nevertheless larger than those betweenDaghestan ethnic groups, which is consistent with the linguistic
and archaeological evidence for their shared descent from a
common ancestral population [14–16].
The genetic diversity among these ethnic groups has been
studied in collaboration with H. Harpending and L. Jorde
(University of Utah) using numerousAlu sequences, short tandem
repeat polymorphisms (STRPs), and mitochondrial DNA hyper-
variable segment 1 [14,15] (see http://harpend.dsl.xmission.com/
daghestan_data for available genetic databases). The results of our
long-term population-genetics study in this region, using a
number of classical and DNA markers, demonstrated that
prolonged reproductive isolation and the severe highland
environment led to high genetic diversity between the Daghestan
ethnic populations and low genetic diversity within them [14,15]:
the FST
1 value for STRP in Daghestan is 0.021, in Africa—0.024,
and in Europe—0.023 [15]. The mean coefficient of inbreeding
and average homozygosity that characterize a within-population
genetic diversity are high (close to the worldwide maximum)
within Daghestan ethnic populations, especially in demographi-
cally ancient primary isolates [14,15].
Because the differences in the demographical ages between
isolates are related to the number of meiosis and recombination
events that occur over generations, and gene drift in different
genetic isolates would be uncorrelated, we suppose that more
genetically homogeneous primary isolates with aggregation of
certain complex disease (e.g., schizophrenia) in comparison
with demographically younger secondary isolates or outbred
populations may have a relatively homogeneous set and fewer
pathogenic loci derived from a limited number of ancestors.
This article extends our previously reported association and
linkages found in several chromosomal regions in some of our
isolates’ pedigrees [16] and describes additional original results
of systematic genome-wide multipoint linkage analyses of
schizophrenia performed in five pedigrees from the ethnically
and demographically diverse genetic isolates.
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Table 1 describes four Daghestan genetic isolates with the
aggregation of schizophrenia-spectrum diseases and pedigrees
ascertained for them. Lifetime morbidity risk (LMR) varied
within the isolates, with values ranging from 1.76 to 2.97%
(Table 1). Total size of the isolates studied varied from 931 toFig. 1. Pedigree branches selected for linkage analysis.
Labels: SCZ, schizophrenia; P/Schizoaffective disease, probable schizoaffective dise
deafness, cardiovascular diseases). All branch members who contributed DNA samp2000 and mean coefficient of inbreeding F varied from 0.007 to
0.012.
Because genome-scan data were available for only a part of
the extended pedigree members we selected five branches from
the pedigrees with the highest density of family members with
genotypes (Fig. 1). The branches selected are fully confirmed
with extended pedigrees by rate of endogamy and consan-ase; SCZ and comorbidity, schizophrenia with comorbidity (mental retardation,
les are marked with the symbol “Y”.
Fig. 1 (continued).
170 K.B. Bulayeva et al. / Genomics 89 (2007) 167–177guineous marriages, as well as by aggregation of affected family
members. In extended pedigrees from the secondary isolate
6011 of ethnic Dargins we selected two branches connected to
each other by a joint ancestor who lived in the seventh
generation retrospectively. All branch members who contrib-
uted DNA samples are marked on Fig. 1 with the symbol “Y”.
Six clinical phenotypes—schizophrenia, probable schizophre-
nia, schizophrenia/suicide, schizoaffective disorder, probable
schizoaffective disorder, and schizophrenia combined withmental retardation and other types of comorbidities—were
ascertained in all five branches (Fig. 1). Of interest with regard
to the well-known schizophrenia clinical heterogeneity are the
between-isolate differences in a number of clinical phenotypes:
in the most demographically ancient genetic isolates, 6022 and
6005, we ascertained two (schizophrenia and probable schizo-
phrenia) and three (schizophrenia, schizoaffective disorder, and
probable schizophrenia) clinical phenotypes, respectively. In
demographically younger secondary isolates, 6034 and 6011,
171K.B. Bulayeva et al. / Genomics 89 (2007) 167–177we ascertained five clinical phenotypes, including the more
complex phenotypes of comorbidity of schizophrenia and
mental retardation (isolate 6034, individuals 24 and 58) and
schizophrenia, mental retardation, and deafness (isolate 6011a,
individuals 29, 30, and 31) (Fig. 1). Updating our own
Diagnostic Interview for Genetic Studies (DIGS) clinical
study data for affected pedigree members demonstrated that
primary genetic isolates tended to have distinct types of
schizophrenia: the primary isolate 6022 is characterized by
aggregation of the disorganized type of schizophrenia and
relatively early average age of onset (20.8±1.5 years). Another
primary isolate, 6005, is characterized by the aggregation of
affecteds with paranoid schizophrenia and by relatively later
average age of onset (24.1±2.15 years).
Non-parametric and parametric linkage results demonstrated
significant cross-isolate differences and similarities in linked
genomic regions and in genetic models. Within-isolate genetic
heterogeneity for schizophrenia was higher in the demographi-
cally younger isolate 6011. Results of the genome-wide
nonparametric linkage analysis in these branches showed
statistically significant (p<0.05) nonparametric linkage (NPL)
scores ranging from 1.4 to 2.4 in all five pedigrees. The number of
linked loci varied in different pedigrees from 2 to 8 and was lower
in the demographically older isolates compared to the pedigrees
from younger ones (Table 2).
Genome-wide parametric linkage analysis in individual
pedigrees demonstrated five, and in overall combined pedi-
grees, six initial linkage peaks that reached the “significant”
level (LOD≥3) (Table 3). The number of statistically signifi-
cant (p≤0.05) suggestive linkage peaks with 1.3<LOD<3.0
varied from 4 to 8 in different pedigrees (Table 3). Fig. 2
presents positive findings of lod scores for chromosomes 1, 10,
11, 12, 17, and 22 in individual and combined pedigreesTable 2
Genome-scan multipoint nonparametric linkage analysis in five pedigrees from Dag
Chromosome Map Primary isolates
6055 6022
1 1q21 0.93 (B) 0.92 (B)
1q41
2 2p22–p25
2q34 1.53 (A)–1.94 (C) 0.9 (B)
3 3p13
3p22–p25
4 4q35
5 5p13
5q23
8 8p11–p22
10 10p12
10q26 0.7 (B)–0.9 (D)
11 11p15–p21 1.12 (A) 1.1 (D)
11q23
12 12q24
17 17p11–p12 1.3 (A) 1.9 (A)–2.31 (C)
18 18p11 1.12 (A)–1.29 (C
22 22q11 1.5 (B)–1.7 (D)
22q13
Number 3 2
p<0.05 for entries in boldface.specifying a dominant or recessive 90% penetrance model of
inheritance and the assumption of heterogeneity (α=0.5).
Pedigrees 6022 and 6005 produced lod scores of 1.72 and
1.8 at regions of 148 and 160 cM under the dominant model
on 1q21–q22 (flanking loci D1S1653–D1S1679 in 6005 and
D1S3723–D1S534 in 6022). The overall lod score for these
two pedigrees was 2.3 with a peak at 152 cM, α=1.0 (Table 3,
Fig. 1).
Weak signals at 1q41–q42 were obtained for pedigree 6011b
(LOD=1.4) under the dominant model and at 1p35–p36 for
6011a (LOD=1.6) under the recessive model (Table 3), which
demonstrates within-pedigree (isolate) genetic heterogeneity of
schizophrenia loci. Similar genetic heterogeneity in these two
branches of extended pedigree 6011 was demonstrated in
several other genomic regions: unlike 6011a, linkage signals
with LOD=1.5–2.0 were found in 6011b at 3p13, 4q13, and
5p13; 6011a showed suggestive-level linkages at 6p22 and
10p13 that were not seen in 6011b (Table 3). At the same time,
these two branches demonstrated a genetic homogeneity in five
of eight and nine genomic regions linked with schizophrenia:
2p24, 11q23, 12q24, 17q12–p11, and 22q13. The overall
combined lod scores across both branches varies from 3.0 to
4.9, α=1.00 (Table 3, Fig. 2).
The peak lod scores at 10q26 varied from 1.96 to 2.4 for
pedigrees 6005 and 6022 under the dominant model of inheritance,
while in the same 10q26 regionwe got in pedigree 6034 a lod score
of 2.7 under the recessivemodel (Table 2, Fig. 2).Also, aLOD=1.6
was obtained for pedigree6034at 11q23under the dominantmodel,
but in two branches of pedigree 6011 lod scores of 1.9–2.1 in the
same genomic region were obtained under the recessive model
(Table 2). Significant lod scores and genetic homogeneity were
found for chromosomes 17 and 22. Three pedigrees, 6005,
6022, and 6034, demonstrated linkage evidences at 17p11–p12hestan genetic isolates
Secondary isolates
6034 6011a 6011b
0.92 (B)
2.13 (B,E) 1.2 (A)–1.3 (C)
1.12 (B)–1.4 (E)
1.2 (A) 1.4 (A)–1.3 (C)
1.43 (A)–1.28 (C)
1.31 (B)–1.5 (E)
1.17 (A)–1.7 (C)
1.9 (B)–1.73 (E)
1.23 (C)–1.07 (D)
1.14 (A)–1.3 (E) 1.5 (B)–1.6 (E)
1.9 (B)–2.3 (E) 0.9–0.89 (B)
1.2 (C)–1.4 (E) 2.1 (B)–2.4 (E) 0.93 (B)
) 1.04 (B)–1.16 (D) 1.48 (B)–1.45 (D)
1.8 (B)–2.3 (E)
2.1 (B)–2.5 (E) 1.04–1.5 (A–E)
7 8 4
Table 3
Genome-wide multipoint parametric linkage analysis in pedigrees ascertained from four Daghestan genetic isolates
Map Primary isolates Secondary isolates Overall
6005 (1) 6022 (2) 6034 (3) 6011a (4) 6011b (5)
LOD,
R/M–D/M
Flanking loci
(peak, cM)
LOD,
R/M–D/M
Flanking loci
(peak, cM)
LOD,
R/M–D/M
Flanking loci
(peak, cM)
LOD,
R/M–D/M
Flanking loci
(peak, cM)
LOD,
R/M–D/M
Flanking loci
(peak, cM)
LOD,
R/M–D/M
Flanking loci
(peak, cM)
1q21–q22 1.8 D/M D1S1653–D1S1679 (160) 1.7 D/M D1S3723–D1S534 (148) 2.3 (1+2)
D/M, α=1.0
D1S534–D1S1653 (152.2)
1q41–q42 1.4 D/M D1S2141–D1S549 (231)
1p35–p36 1.6 R/M D1S552–D1S1622 (46.4)
2q22–q31 2.3 R/M D2S1353–D2S1776 (169)
2q37 1.5 D/M D2S1363–D2S427 (225)
2p24 3.1 D/M D2S1788–D2S1356 (57) 1.8 D/M D2S2976–D2S2952 (10) 4.5 (4+5)
D/M, α=1.0
D2S1400–D2S1360 (21)
3p13 1.7 D/M D3S4542–D3S2406 (90)
3p21 1.8 D/M D3S2432–D3S1768 (48)
3q28 1.9 D/M D3S2418–D3S1311 (209.7)
4q13 1.5 D/M D4S2367–D4S3243 (68)
4q35 1.8 R/M D4S1652 (216)
5p13 2.0 D/M D5S2848–D5S1470 (52)
5q34 1.3a R/M D5S1456–D5S211 (180)
6p22 2.2 D/M F13A1–D6S2434 (9)
8p23 1.6a R/M D8S264–D8S277 (3)
10q26 2.4 D/M D10S1230–D10S1213 (136) 1.96 D/M D10S1213–D10S1248 (153) 2.7 R/M D10S1230–D10S1213
(136)
3.4 (1+2)
D/M, α=1.0
D10S1213–D10S1248 (141)
10p13 2.4 D/M D10S1426–D10S1208 (26)
11p15 2.0 R/M D11S1984–D11S2362 (8)
11q23 1.6 D/M D11S912 (158) 2.1 R/M D11S1986–D11S1998 (113) 1.9 R/M D11S2000–D11S1986 (103) 3.03 (4+5)
R/M, α=1.0
D11S1986–D11S1998 (107)
12q24 3.1 R/M D12S395–D12S2078 (145) 1.27 R/M D12S395–D12S2078 (145) 3.87 (4+5)
R/M, α=1.0
D12S395–D12S2078 (145)
13p11–p12 1.4 D/M D13S787–D13S1493 (3)
17p11–p12 2.5 R/M D17S1298–D17S974 (13) 3.7 R/M D17S1303–D17S947 (27.5) 1.7 a R/M D17S974–D17S1303
(21)
5.46 (1–3)
R/M, α=1.0
D17S1303–D17S947 (24.9)
17q12–p11 2.3 D/M D17S947–D17S2196 (40) 1.4 D/M D17S1303–D17S947 (34) 2.98 (4+5)
D/M, α=1.0
D17S1294–D17S1293 (52)
18p11 1.5 R/M D18S481–D18S986 (21) 1.98 R/M D18S481–D18S976
(10.5)
2.97 (2+3)
R/M, α=1.0
D18S1481–D18S976 (13)
22q11 3.02 D/M D22S420–D22S345 (3) 4.4 D/M D22S420–D22S345 (3) 8.7 (1+3+4+5)
D/M, α=1.0
6.7 (1+3)
D/M, α=1.0
D22S420–D22S345 (6)
D22S420–D22S345 (3)
22q13 2.8 D/M D22S683–D22S445 (32) 3.1 D/M D22S683–D22S445 (32) 2.1 D/M D22S685–D22S683 (32) 6.7 (1+3+4+5)
D/M, α=0.75
4.87 (4+5)
D/M, α=1.0
D22S685–D22S683 (32)
LOD≥3.0 1 1 1 3 – 9
LOD<3>1.3 6 4 8 5 8 3
Total 7 5 9 8 9 11
LOD≥1.3 statistically significant, p≤0.05.
a Results obtained in smaller branch of pedigree #6034.
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Fig. 2. The multipoint lod score for linkage of schizophrenia across chromosomes 1, 10, 11, 12, 17, and 22 in five pedigree branches ascertained from Daghestan
genetic isolates. Ellipses are present on the portion of genomic regions common for different isolates’ pedigree linked intervals.
173K.B. Bulayeva et al. / Genomics 89 (2007) 167–177under the recessive model, with an overall lod score of 5.46
(α=1.0). Two branches of pedigree from isolate 6011 showed
linkages in the closest region at 17q12–p11 under the dominant
model, with an overall lod score for both branches of 2.98
(α=1.0).
Two high peaks of lod scores at 22q11 and at 22q13 were
found in four of five analyzed pedigrees under the dominant
model (Table 3, Fig. 2). The strongest linkage evidence, with lod
score of 4.4 at 22q11 and 2.8 at 22q13, was obtained in pedigree
6034. The reliability of these lod scores in this pedigree were
rechecked using an allele frequencies (“locus.dat”) file based on
data of 31 unrelated subjects selected from the same isolate, 6034.
The results obtained show that the lod scores increased at 22q11
from 4.4 to 4.57 and decreased at 22q13 from 2.8 to 1.8 (Fig. 3).
The combined lod score for isolates 6005 and 6034 at
22q11 is 6.7 (α=1.0), and overall for two branches of
pedigree 6011 the lod score at 22q13 is 4.87 (α=1.0). Overallfor these four isolate pedigrees the lod score at 22q11 is 8.7
and at 22q13 is 6.7 (α=0.75).
In total, linkages with schizophrenia have been found in 26
genomic regions of 14 chromosomes; among them linkage
evidence (LOD≥3.0) was found in only 5 genomic regions,
2p24 (6011a), 12q24 (6011a), 17p11–p12 (6022), 22q11 and
22q13 (6005, 6034, and 6011a), as well as in 9 genomic regions
for combined pedigrees (2p24, 10q26, 11q23, 12q24, 17p11–
p12, 17q12–p11, 18p11, 22q11, and 22q13) (Table 3).
Discussion
The aggregation of distinct types of schizophrenia and higher
clinical homogeneity were found in the demographically older
genetic isolates. The unified clinical, genomic, and statistical
design we used enabled us to separate the linked and unlinked
pedigrees in an unbiased fashion for each genomic location. We
Fig. 3. Parametric linkage analysis results for pedigree 6034 using the ‘locus.dat’
file based on chromosome 22 loci allele frequencies evaluated among unrelated
members of the same isolate (- - -) and among unrelated subjects in four isolates
(—).
174 K.B. Bulayeva et al. / Genomics 89 (2007) 167–177did not find any initial linkage signal in NPL analysis that
reached “significant” as evidence for linkage, according to the
criteria of Lander and Kruglyak [10]. Instead we found lesser
NPL scores in certain pedigrees ranging from 1.4 to 2.4
(Table 2). Initial linkage signals in more powerful parametric
linkage analysis reached significance (LOD≥3) in five
genomic regions for five individual pedigrees and in nine
genomic regions for combined pedigrees. Suggestive evidence
with lod scores ranging from 1.4 to 2.8 was obtained in different
isolate pedigrees (Table 3). The highest lod score of 4.4 at
22q11 was obtained for pedigree 6034, and a second high
LOD of 3.7 was obtained at 17p11–p12 in pedigree 6022
(Table 3). The pedigrees with disorganized schizophrenia
had the lowest number of linked genomic regions of both
evident and suggestive levels; the highest lod scores were
obtained at 17p11–p12 (Tables 2 and 3). Other isolate
pedigrees with predominant aggregation of paranoid schizo-
phrenia (6005, 6011, and 6034) demonstrated suggestive
linkages in seven to nine genomic regions and the highest
lod scores at 22q11.
Lod scores recalculated in pedigree 6034 using allele data
from the same isolate’s unrelated subjects demonstrated an
increased peak at 22q11, while a second peak at 22q13 was
decreased (Fig. 3). This supports the significance of the peak at
22q11 for the disease susceptibility gene location, as well as the
reliability of the lod scores obtained in our study.
Linkages in 6 of 26 genomic regions demonstrated genetic
homogeneity of the disease loci across some pedigrees that can
be explained by a common metahaplotype block with
pathogenic loci derived from an ancestral metapopulation
saved (undissolved) over generations in the isolates because
of a high rate of endogamy and inbreeding.
The average number of linkage evidences in primary isolates
is 1.0, in secondary isolates 1.3, while the average suggestive
and total numbers of linkages (1.3<LOD<3.0) in these isolate
groups are 5 and 6.5 vs 7 and 8.6, respectively, indicating a
possible increase of about 30% for schizophrenia geneticheterogeneity in demographically younger and more hetero-
geneous isolates in comparison with demographically older,
more homogeneous, isolate pedigrees.
The linkage analysis results obtained in this study support
findings of linkages and candidate genes identified by other
investigators [24,25]. A schizophrenia susceptibility locus at 2q
found in isolate pedigree 6022 was reported for Finland genetic
isolates [26] and has also been supported in a Kosrae isolate
study [3]. Linkage in the region of 10q26 was obtained in three
of five pedigrees and may be connected with the SCZD11 locus,
as was reported earlier [27]. In addition, evidence for 11q23
obtained in two branches of pedigree 6011 (Table 2) supports a
region that has been implicated through DRD2 in many studies
of schizophrenia genetics [24,28,29]. A limited number of
studies have reported evidence of linkage of schizophrenia with
markers in the proximity of chromosomal region 17p11: such
linkages at 17p11.2–q25.1 were reported for one UK pedigree
[27] and at 17q (63.6–94.0 cM) in a meta-analysis [9]. The
pathophysiological mechanisms of the linkages found in 17p
may be related to the serotonin transporter gene 5-HTT, which is
significant in a pattern of schizophrenic symptoms [26,30], or
with the RAII gene [31].
Suggestive evidence for linkage and association of schizo-
phrenia with the chromosome 22q11–q12 region has been
reported by several independent groups [3,32,33], although
highly statistically significant and reliable evidence has not
been detected. In addition, schizophrenia pedigrees drawn from
Iceland and the United Kingdom yielded no evidence for
linkage with a schizophrenia susceptibility locus on 22q
[34,35]. Further, Riley et al. [36] found no evidence to support
a schizophrenia susceptibility locus on chromosome 22 in a
sample of South African Bantu families. Yet, two recent meta-
analyses have found that the collective evidence from all
genome-wide linkage scans does support the presence of a
schizophrenia-susceptibility locus in this region of chromosome
22 [9,37]. The gene COMT (116790) is located on the
chromosome 22q11.2 region and is a strong candidate gene
for schizophrenia owing to the role this enzyme has in
dopamine metabolism [33]. In addition, COMT is located
within the region of the chromosome that is deleted in VCFS
and DiGeorge Syndrome, both of which have also been
associated with high rates of schizophrenia [33,38]. Other
potential candidate genes that were significantly unregulated in
schizophrenia are the apolipoprotein genes, which are located in
close proximity to each other on chromosome 22q12 [39–41].
The results obtained in our study appear to support this region as
harboring two schizophrenia-susceptibility genes, as we
detected two significant linkage peaks at 22q11 and 22q13
separated by a clear boundary of no linkage (Table 3, Fig. 2).
Thus, the cross-isolate design used for mapping genes of
complex diseases provides a unique setting for observing
reliable ancestral metahaplotypes with pathogenic loci, as well
as population-specific linked loci. The summarized cross-
isolate results indicated prominent within-and between-isolate
differences in clinical and genetic heterogeneity: most
demographically ancient isolates have twofold fewer numbers
of distinct clinical phenotypes and fewer numbers of linked
175K.B. Bulayeva et al. / Genomics 89 (2007) 167–177genomic regions compared to demographically younger
isolates. Therefore mapping genes of any complex disease
(e.g., schizophrenia) in demographically and ethnically diverse
primary genetic isolates may be more time and cost effective
than in demographically younger ones or in heterogeneous
outbred populations.
A study at higher genotyping density across the regions of
interest and fluorescence in situ hybridization analyses are
currently under way.Materials and methods
Ascertainment and clinical phenotype description
Written informed consent was obtained from each participant who provided
a blood sample and/or provided clinical information. The Daghestan IRB at the
Daghestan Center of the Russian Academy of Sciences approved this study.
Two-thirds of the Daghestan people live in remote highland villages that have
been geographically and genetically isolated for thousands of years [17].
Two primary and two secondary isolates with aggregation of schizophrenia
among three indigenous ethnic groups (Laks, Dargins, and Tindals) were
ascertained based on state medical records and our own 1994–2004 expedition’s
studies. According to archeological and ethnological data, the highland primary
isolates of ethnic Dargins (6022) and ethnic Laks (6005) were founded about
4000–5000 years ago. Another ethnic Dargins isolate, 6011, located in a foothill
region, has significant admixture because it was founded by highlanders who
migrated from different remote villages to this foothill, which has a much better
climate and more land for agricultural activity. Ethnic Tindal is one of smallest
Daghestan ethnic groups (unilingual village 6034) and was fully moved by
Stalin’s government in 1944 from a remote highland region to a new, for them,
lowland village of ethnic Kumiks and Avars. Our study showed an elevated rate
of interethnic marriages (about 35%) and average heterozygosity of STRP
among current generations of ethnic Tindals. Therefore the isolate 6034 is closer
to the secondary isolate than to the primary one. Statistical data on total size, sex
ratio, and marriage structure were collected in these local isolates using official
regional administration documents and archives, as well as our own surveys for
demographical study. Inbreeding has occurred when an individual has one or
more common ancestors, that is, when both father and mother are descended
from one or more common ancestors. The degree of inbreeding is commonly
expressed using Sewall Wright’s formula and it is often known as Wright’s
coefficient of inbreeding F. We used a routine method of F evaluation that is
based on analysis of marriage types in three previous generations of every
subject in the representative and randomized groups selected for every local
isolate during our expeditions.
Because of the ethnic groups’ traditions to keep and relay to their
descendents (progeny) any information about their ancestors, going back for 7
generations, we were able to reconstruct the affected subject pedigrees up to
9–12 generations retrospectively, containing 300–500 members in our
preliminary studies [16]. Additional information about certain villages’ history
and demography, including morbidity in the families, mortality, and fertility,
was gleaned from the regional medical archives and from the annual Russian
governmental census, which has been performed in the Daghestan since 1897.
The analysis of the data collected allowed reconstruction of detailed
genealogical information in extended multigenerational pedigrees with
description of the ancestors’ names, health condition, life spans, occupations,
marriages, number of children, etc. Any ancestors with known mental diseases
were marked as “probably had schizophrenia” and in linkage analysis they
were designated as “unknown” by phenotype.
All mentally ill patients of current generations were diagnosed during
hospitalization in two Daghestan psychiatric hospitals. Affected or probably
affected subjects were interviewed during our expeditions by two psychiatrists
from the Daghestan psychiatric hospitals—R. Kurbanov and U. Guseynova—
using a Russian translation of the structured psychiatric interviews, the DIGS and
the Family Interview for Genetic Studies [18], based on DSM-IV criteria. All
interviews were carried out in Russian, which is the “common language” used bythe differing ethnic populations since the early 1900s. The diagnoses obtained
were compared and discrepancies were resolved by discussion with collaborators
at the University of California at San Diego and by collecting additional
information from a subject. Unresolved cases were coded as unknown. Based on
these interviews, it is quite clear that the presentation and course of schizophrenia
in Daghestan are similar to those found in America and elsewhere [16]. The final
set of diagnoses and pedigrees collected was entered into the Progeny database, a
proprietary relational genetic database based on Sybase (Progeny, Inc.).
The prevalence of schizophrenia in the isolates was measured by the
epidemiological index of LMR, which permits estimation of the population
“schizophrenia load” and allows for comparison between populations [1]. The
LMR coefficient is a probability that a subject who has survived until the age of
manifestation of schizophrenia (14–45 years) will develop the disease. This
method includes a correction for sample size and takes into account the amount
of unaffected subjects using the formula LMR ¼ a=½N  ðno þ 0:5nwÞ;where a
is the number of schizophrenic patients examined, N is the total population size,
no is the number of subjects who are younger than the lower age limit for
schizophrenia onset (children below 15 years of age), and nw is the number of
unaffected subjects whose current ages fall within the interval of schizophrenia
onset (15–45 years).
Pedigree analysis
Blood samples were collected from three or four current generations of
affected and healthy pedigree members deemed most informative. Using
standard DNA isolation methods, approximately 400 μg of DNA was isolated
from each subject. This DNA was sent to the high-throughput genotyping
facilities at the Mammalian Genotyping Service operated by Dr. Jim Weber’s
laboratory at the Marshfield Medical Research Foundation (NIH/NHLBI
grant, 1997–1998, Drs. H. Coon and K. Bulayeva). A 10-cM genome scan on
Daghestan pedigrees comprising about 300 individuals generated about
80,000 genotypes (Weber/CHLC9.0 [19] as described) (http://research.
marshfieldclinic.org/genetics/sets/combo.html). The Weber/CHLC map con-
tains mostly tri-and tetranucleotide repeat markers, which are, in general,
easier to score than dinucleotide markers. The genotypes at each locus were
checked for Mendelian inconsistencies in the pedigrees using the program
PedCheck [20].
Due to the great complexity and numerous inbred loops in our pedigrees, the
only software that could utilize all pedigree information for linkage and
haplotype analysis was SimWalk2 [21] based on the Markov chain/Monte Carlo
algorithm, which is able to analyze large pedigrees since it considers the
underlying configurations in proportion to their actual likelihood. Nonpara-
metric linkage analysis, also known as allele-sharing statistics, is independent of
specific models for the inheritance of the trait phenotype [21]. This analysis is
based on identity-by-descent measurements at the marker loci. If a marker is
linked to a disease locus, one expects to see a clustering among the affecteds of a
few marker alleles that descended from the pedigree founders. SimWalk2 reports
five statistics (A, B, C, D, and E) and their empirical p values, which measure the
degree of clustering and significance. The statistic A is the number of different
founder alleles contributing to affected individuals and it is the most powerful at
detecting linkage to a recessive trait. Statistic B is the maximum number of
alleles among those affected, descended from any one founder allele, and it is the
most powerful at detecting linkage to a dominant trait. Statistic C is the
“entropy” of the marker alleles among those affected. Statistic D is the extent of
the allele sharing among all affected pairs as measured by their identity-by-
descent kinship coefficient. Statistic E is the NPL statistic as implemented in
Gene Hunter [22].
Parametric linkage analysis is performed using the method of location scores
that indicate the likelihood of several putative positions, among the marker loci,
for the trait locus. Based on pedigree structure and NPL results, we chose a
dominant or recessive model for all pedigrees. Multipoint parametric linkage
analysis specifying a dominant 90% penetrance model of inheritance, the
disease allele frequency 0.02, and the assumption of genetic heterogeneity was
performed to evaluate regions of the genome demonstrating increased allele
sharing, as measured by lod scoring. SimWalk2 combines precomputed scores
on individual pedigrees and then computes the empirical p values for both
individual pedigrees and the overall dataset: (1) for α=0.5 (i.e., assuming locus
heterogeneity) and (2) maximized over a grid of α values.
176 K.B. Bulayeva et al. / Genomics 89 (2007) 167–177Estimating allele frequencies
An accurate assessment of population allele frequencies is important to
reduce the chance of a false-positive lod score or a false-positive result when
performing linkage analyses. For the Daghestan isolates, in which we have
ascertained several unrelated pedigrees, allele frequencies were estimated from
“marry-in” individuals of the noninbred branches of families and from unrelated
individuals [23]. Due to the common ancestral metapopulation for Daghestan
indigenous ethnic groups, we separated all marry-in individuals and unrelated
subjects into a file of allele frequencies. To avoid any possible false-positive or
false-negative linkage results, we recalculated lod scores using allele data from
the same isolate’s unrelated subjects.Acknowledgments
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